| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/30/2008 | WO2008131163A1 Enzymatic anticancer therapy |
| 10/30/2008 | WO2008131103A2 Drug discovery methods for aurora kinase inhibitors |
| 10/30/2008 | WO2008130920A1 Biosensor and methods of reagent patterning for a multiple well biosensor |
| 10/30/2008 | WO2008130887A1 Biomarkers for follicular thyroid carcinoma and methods of of use |
| 10/30/2008 | WO2008130802A1 Process challenge device for assessing the effective performance of a biocontamination deactivation process |
| 10/30/2008 | WO2008130655A1 Methods for counting cells |
| 10/30/2008 | WO2008130568A1 Compositions and methods for treating and diagnosing cancer |
| 10/30/2008 | WO2008130516A1 Epigenetic biomarkers for early detection, therapeutic effectiveness, and relapse monitoring of cancer |
| 10/30/2008 | WO2008130445A2 Rapid detection microorganisms in fluids |
| 10/30/2008 | WO2008130417A1 Broad-based disease association from a gene transcript test |
| 10/30/2008 | WO2008130394A2 Array for detecting microbes |
| 10/30/2008 | WO2008130327A1 Biointerfaces for biomolecule detection |
| 10/30/2008 | WO2008130263A1 Monomer and composition for producing low-percentage hydrogel and/or hydrogel having a low cross linkage content, a hydrogel and a biochip based thereon |
| 10/30/2008 | WO2008130034A1 Polyamino acid synthetase and gene encoding the same |
| 10/30/2008 | WO2008130027A1 Improved bacterial two-hybrid assay |
| 10/30/2008 | WO2008130009A1 Method for determination of progression risk of glaucoma |
| 10/30/2008 | WO2008130008A1 Method for determination of onset risk of glaucoma |
| 10/30/2008 | WO2008129838A1 Germ cell marker using fish vasa gene |
| 10/30/2008 | WO2008129419A2 Method for detecting and/or isolating mycobacteria |
| 10/30/2008 | WO2008129265A1 Diagnostics and therapeutics for diabetic nephropathy involving ccl18 |
| 10/30/2008 | WO2008128930A1 Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
| 10/30/2008 | WO2008128559A1 Method for providing a compound capable of interfering with a distorted chondrocyte phenotype |
| 10/30/2008 | WO2008128399A1 Device for washing and hybridization of biochips |
| 10/30/2008 | WO2008128352A1 Methods and compositions for signal amplification |
| 10/30/2008 | WO2008128333A1 A method to distinguish antibody-mediated tissue rejection from t cell-mediated tissue rejection |
| 10/30/2008 | WO2008128331A1 Process for sequestering carbon dioxide |
| 10/30/2008 | WO2008112898A3 Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes |
| 10/30/2008 | WO2008110367A3 Method for the genomic typing of erythrocyte systems, oligonucleotide probes and relative diagnostic kits |
| 10/30/2008 | WO2008109127A3 New tumor mouse models using lentiviral vectors |
| 10/30/2008 | WO2008109030A3 Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer |
| 10/30/2008 | WO2008108843A3 Methods and kits for amplifying dna |
| 10/30/2008 | WO2008106491A3 Peptides that interact with topoisomerase i and methods thereof |
| 10/30/2008 | WO2008105792A3 Methods for depositing nanomaterial, methods for fabricating a device, methods for fabricating an array of devices and compositions |
| 10/30/2008 | WO2008104857A3 Method for predicting susceptibility of hiv infection |
| 10/30/2008 | WO2008103900A3 Selection and enrichment of proteins using in vitro compartmentalization |
| 10/30/2008 | WO2008099280A3 Regulation of expression of pi3kb protein in tumors |
| 10/30/2008 | WO2008098995A9 Genes involved in mitochondrial biogenesis |
| 10/30/2008 | WO2008088884A3 Enhanced cell-free synthesis of active proteins containing disulfide bonds |
| 10/30/2008 | WO2008084409A3 Means for identifying a strain isolated from a clinical sample at the species and/or subspecies level |
| 10/30/2008 | WO2008079374A3 Methods and compositions for selecting and using single nucleotide polymorphisms |
| 10/30/2008 | WO2008073914A3 Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi |
| 10/30/2008 | WO2008073457A3 Methods for determining prognoses and therapeutic interventions for ovarian carcinomas |
| 10/30/2008 | WO2008070352A3 Efficient arrays of amplified polynucleotides |
| 10/30/2008 | WO2008063752A3 An enzyme regulating ether lipid signaling pathways |
| 10/30/2008 | WO2008058282A3 Methods and compositions for large-scale analysis of nucleic acids using dna deletions |
| 10/30/2008 | WO2008057795A3 Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera |
| 10/30/2008 | WO2008054432A3 Oligonucleotide microarray for identification of pathogens |
| 10/30/2008 | WO2008051511A3 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof |
| 10/30/2008 | WO2008051290A3 Steroid responsive nucleic acid expression and prediction of disease activity |
| 10/30/2008 | WO2008048342A3 Microarray for detecting and quantifying microrna |
| 10/30/2008 | WO2008039772A3 Polymerase variants for dna sequencing |
| 10/30/2008 | WO2008033461A3 Methods for the identification, evaluation and treatment of patients having cc-chemokine receptor 2(ccr-2) mediated disorders |
| 10/30/2008 | WO2008028024A3 Automated parallel oligonucleotide synthesis |
| 10/30/2008 | WO2008024832A3 Methods for isolating and using pituitary adenoma stem cells and pituitary adenoma cells |
| 10/30/2008 | WO2008022035A3 Methods for identifying cellular modulators of disaggregation activity or aggregation activity in an animal |
| 10/30/2008 | WO2008014050A3 Assays based on light emission from analyte complexes within a cassette |
| 10/30/2008 | WO2008008444A3 Methods and reagents for detecting hantavirus |
| 10/30/2008 | WO2008008383A3 System and methods for measuring a skin protection factor |
| 10/30/2008 | WO2007149455A3 System and method for identification of desired traits in animals |
| 10/30/2008 | WO2007145942A3 A rapid, semi-automated method to detect respiratory virus infected cells in nasopharyngeal samples using direct fluorescent antibody |
| 10/30/2008 | WO2007143656A3 Dna storage and display vessell and method |
| 10/30/2008 | WO2007133905A3 Detecting diastolic heart failure by protease and protease inhibitor plasma profiling |
| 10/30/2008 | WO2007130831A3 Methods and apparatus for identifying disease status using biomarkers |
| 10/30/2008 | WO2007115095A3 Systems and methods for using molecular networks in genetic linkage analysis of complex traits |
| 10/30/2008 | WO2007106790A3 A gene and pathway and their use in methods and compositions for predicting onset or progression of autoimmune and/or autoinflammatory diseases |
| 10/30/2008 | WO2007104052A3 Apparatus and methods for applications of genomic microarrays in screening, surveillance and diagnostics |
| 10/30/2008 | WO2007103430A3 Method and system for generating sample plate layout for validation |
| 10/30/2008 | WO2007100859A3 Gene predictors of response to metastatic colorectal chemotherapy |
| 10/30/2008 | WO2007095186A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer |
| 10/30/2008 | WO2007092181A3 Compositions and methods for modulating translational repression |
| 10/30/2008 | WO2007087310A3 Nucleic acid analysis using sequence tokens |
| 10/30/2008 | WO2007078599A8 Functional arrays for high throughput characterization of gene expression regulatory elements |
| 10/30/2008 | WO2007074193A3 Method for the analysis of differential expression in colorectal cancer |
| 10/30/2008 | WO2007067960A3 The or gene and its use in manipulating carotenoid content and composition in plants and other organisms |
| 10/30/2008 | WO2007024715A3 Dual variable domain immunoglobin and uses thereof |
| 10/30/2008 | WO2005017110A3 Engineered proteases for affinity purification and processing of fusion proteins |
| 10/30/2008 | WO2004087735A3 Proteolytic and covalent antibodies |
| 10/30/2008 | US20080271207 Lipase Polypeptide |
| 10/30/2008 | US20080271166 Polypeptide for use as highly efficient gene targeting tool in mammalian cells |
| 10/30/2008 | US20080269637 Laser system for separating and obtaining objects of a preparation |
| 10/30/2008 | US20080269475 Sorbent for Nucleic Acids, Comprising Acid-Activated Layer Silicate |
| 10/30/2008 | US20080269346 B-Blocker Pharmacogenetics in Heart Failure |
| 10/30/2008 | US20080269341 administering to patient fenretinide for treating an infectious disease, or bone disease osteopenia or osteoporosis; decreasing arachidonic acid levels, increasing docosahexaenoic acid; for increase osteoblast formation; diagnostic and screening disease based on the lipid level |
| 10/30/2008 | US20080269262 Therameutin Modulators |
| 10/30/2008 | US20080269259 Regulation of Autophagy and Cell Survival |
| 10/30/2008 | US20080269188 Determine variable response in patients sensitive to cardiovascular disease, high cholesterol, diabetes, metabolism disorders; detecting concentration of polypeptide containing proline as indicator of good response to statin therapy; drug design |
| 10/30/2008 | US20080269158 E2epf Ubiquitin Carrier Protein-Von Hippel-Lindau Interaction and Uses Thereof |
| 10/30/2008 | US20080269157 Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations |
| 10/30/2008 | US20080269155 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 10/30/2008 | US20080269152 Nucleic acid binding oligonucleotides |
| 10/30/2008 | US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene |
| 10/30/2008 | US20080269129 Polypeptide and dna thereof useful as a neovascular marker |
| 10/30/2008 | US20080269118 Identifying molecule suitable for treatment, prophylaxis or alleviation of a Gpr100 associated disease, in particular diabetes and obesity, by determining whether candidate molecule is an agonist or antagonist of Gpr100 polypeptide, in which Gpr100 polypeptide comprises specific amino acid sequence |
| 10/30/2008 | US20080269113 P53 binding t cell receptor molecules |
| 10/30/2008 | US20080269106 Methods and Compositions for Diagnosis and Treatment of Disorders Involving Macrophages |
| 10/30/2008 | US20080269103 Diagnostic and Therapeutic Use of the Kcne4 Gene and Protein for Alzheimer's Disease |
| 10/30/2008 | US20080269074 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
| 10/30/2008 | US20080269067 Companion diagnostic assays for cancer therapy |
| 10/30/2008 | US20080269065 Conformationally Constrained Analytical Probes |
| 10/30/2008 | US20080269064 Method and Kit for Detecting Components in a Sample |